COVAXIN
Suspension of supply |
Product Overview
Type: Covid-19 vaccine (Whole Virion Inactivated Corona Virus vaccine)
INN: N/A
Trade name: COVAXIN®
EUL holder: Bharat Biotech International Ltd.
Country: India
Responsible NRA: Central Drugs Standard Control Organization (CDSCO)
Country: India
WHO EUL recommendation
Effective date: 03 November 2021
Product description
Pharmaceutical Form: Suspension for injection
Presentation: 2 mL, 3mL, 5 mL and 10 mL vial
Number of doses: 1 dose, 5 doses, 10 doses and 20 doses (0.5 mL per dose)
Route of administration: Intramuscular
Age indication: 18 years and older
Shelf – life: 9 months Storage temperature: 2°C to 8°C
Vaccine Vial monitor (VVM): None
Preservative: Phenoxy ethanol with concentration: 2.5 mg/dose
Adjuvant: None
Diluent: None
Handling of opened multi-dose vials:
The vaccine can be kept and used for up to 28 days after opening, in accordance with WHO Policy Statement WHO/IVB/14.07 on Multi-dose Vial Policy (MDVP).
Packaging description
Secondary packaging: |
a) Single dose presentation b) 5 doses presentation c) 10 doses presentation b) 20 doses presentation |
Tertiary packaging: |
a) Single dose presentation b) 5 doses presentation c) 10 doses presentation d) 20 doses presentation |
Manufacturing sites
Bharat Biotech
Genome Valley, Shamirpet Mandal Medchal-Malkajgiri District
Telangana, 500078 - INDIA